{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T01:38:39Z","timestamp":1778549919937,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ajpm-online.net","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Medicine"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.amepre.2018.03.015","type":"journal-article","created":{"date-parts":[[2018,5,16]],"date-time":"2018-05-16T20:05:53Z","timestamp":1526501153000},"page":"19-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era"],"prefix":"10.1016","volume":"55","author":[{"given":"Fredrick","family":"Oakley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed M.","family":"Desouki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9391-4156","authenticated-orcid":false,"given":"Manideepthi","family":"Pemmaraju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia M.","family":"Gargano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauri E.","family":"Markowitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7192-9904","authenticated-orcid":false,"given":"Martin","family":"Steinau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth R.","family":"Unger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuwei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oluwole","family":"Fadare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie R.","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.amepre.2018.03.015_bib1","unstructured":"National Cancer Institute. SEER stat fact sheets: cervix uteri cancer. http:\/\/seer.cancer.gov\/statfacts\/html\/cervix.html. Accessed May 11, 2017."},{"key":"10.1016\/j.amepre.2018.03.015_bib2","series-title":"United States Cancer Statistics: 1999\u20132014 Incidence and Mortality Web-based Report","year":"2017"},{"issue":"2","key":"10.1016\/j.amepre.2018.03.015_bib3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3322\/caac.21262","article-title":"Global cancer statistics, 2012","volume":"65","author":"Torre","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"7188","key":"10.1016\/j.amepre.2018.03.015_bib4","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1136\/bmj.318.7188.904","article-title":"Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics","volume":"318","author":"Quinn","year":"1999","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.amepre.2018.03.015_bib5","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","article-title":"Human papillomavirus is a necessary cause of invasive cervical cancer worldwide","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"issue":"24","key":"10.1016\/j.amepre.2018.03.015_bib6","doi-asserted-by":"crossref","first-page":"12180","DOI":"10.1073\/pnas.89.24.12180","article-title":"Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic","volume":"89","author":"Kirnbauer","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"10.1016\/j.amepre.2018.03.015_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/jnci\/93.4.284","article-title":"Safety and immunogenicity trial in adult volunteers of a human papillomavirus 16 L1 virus-like particle vaccine","volume":"93","author":"Harro","year":"2001","journal-title":"J Natl Cancer Inst"},{"issue":"2","key":"10.1016\/j.amepre.2018.03.015_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s10552-011-9877-6","article-title":"The HPV vaccine impact monitoring project (HPV-IMPACT): assessing early evidence of vaccination impact on HPV-associated cervical cancer precursor lesions","volume":"23","author":"Hariri","year":"2012","journal-title":"Cancer Causes Control"},{"issue":"16","key":"10.1016\/j.amepre.2018.03.015_bib9","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1002\/cncr.29266","article-title":"Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States","volume":"121","author":"Hariri","year":"2015","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.amepre.2018.03.015_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.vaccine.2012.10.092","article-title":"Impact of human papillomavirus (HPV) vaccination on HPV 16\/18-related prevalence in precancerous cervical lesions","volume":"31","author":"Powell","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.amepre.2018.03.015_bib11","unstructured":"National Center for Health Statistics. Vintage 2015 postcensal estimates of the resident population of the United States (April 1, 2010, July 1, 2010-July 1, 2015), by year, county, single-year of age (0, 1, 2, \u2026, 85 years and over), bridged race, Hispanic origin, and sex. Prepared under a collaborative arrangement with the U.S. Census Bureau. www.cdc.gov\/nchs\/nvss\/bridged_race.htm. Published 2015. Accessed May 11, 2017."},{"key":"10.1016\/j.amepre.2018.03.015_bib12","unstructured":"National Center for Health Statistics. Bridged-race intercensal estimates of the resident population of the United States for July 1, 2000-July 1, 2009, by year, county, single-year of age (0, 1, 2, \u2026, 85 years and over), bridged race, Hispanic origin, and sex. Prepared under a collaborative arrangement with the U.S. Census Bureau. www.cdc.gov\/nchs\/nvss\/bridged_race.htm. Accessed May 11, 2017."},{"issue":"3","key":"10.1016\/j.amepre.2018.03.015_bib13","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"427","key":"10.1016\/j.amepre.2018.03.015_bib14","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1080\/01621459.1994.10476818","article-title":"Estimation of regression coefficients when some regressors are not always observed","volume":"89","author":"Robins","year":"1994","journal-title":"J Am Stat Assoc"},{"issue":"8","key":"10.1016\/j.amepre.2018.03.015_bib16","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1158\/1055-9965.EPI-13-0272","article-title":"Declining rates of high-grade cervical lesions in young women in Connecticut, 2008\u20132011","volume":"22","author":"Niccolai","year":"2013","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"6","key":"10.1016\/j.amepre.2018.03.015_bib17","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1001\/jamaoncol.2016.3609","article-title":"Population-based incidence rates of cervical intraepithelial neoplasia in the human papillomavirus vaccine era","volume":"3","author":"Benard","year":"2017","journal-title":"JAMA Oncol"},{"issue":"12","key":"10.1016\/j.amepre.2018.03.015_bib18","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.2105\/AJPH.2016.303472","article-title":"Ecological association of human papillomavirus vaccination with cervical dysplasia prevalence in the United States, 2007\u20132014","volume":"106","author":"Flagg","year":"2016","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.amepre.2018.03.015_bib19","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1097\/AOG.0b013e3181c6f8a4","article-title":"ACOG Practice Bulletin no. 109: Cervical cytology screening","volume":"114","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"12","key":"10.1016\/j.amepre.2018.03.015_bib20","doi-asserted-by":"crossref","first-page":"880","DOI":"10.7326\/0003-4819-156-12-201206190-00424","article-title":"Screening for cervical cancer: U.S. Preventive Services Task Force recommendation statement","volume":"156","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.amepre.2018.03.015_bib21","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ajog.2007.07.047","article-title":"2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests","volume":"197","author":"Wright","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.amepre.2018.03.015_bib22","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/AOG.0b013e31818f5008","article-title":"Evidence for frequent regression of cervical intraepithelial neoplasia\u2013grade 2","volume":"113","author":"Castle","year":"2009","journal-title":"Obstet Gynecol"},{"issue":"29","key":"10.1016\/j.amepre.2018.03.015_bib23","doi-asserted-by":"crossref","first-page":"784","DOI":"10.15585\/mmwr.mm6429a3","article-title":"National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years\u2014United States, 2014","volume":"64","author":"Reagan-Steiner","year":"2015","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"10.1016\/j.amepre.2018.03.015_bib24","doi-asserted-by":"crossref","first-page":"e20151968","DOI":"10.1542\/peds.2015-1968","article-title":"Prevalence of HPV after introduction of the vaccination program in the United States","volume":"137","author":"Markowitz","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.amepre.2018.03.015_bib25","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1473-3099(14)71073-4","article-title":"Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis","volume":"15","author":"Drolet","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.amepre.2018.03.015_bib26","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/S1473-3099(15)00055-9","article-title":"Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study","volume":"15","author":"Chow","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"10.1016\/j.amepre.2018.03.015_bib27","doi-asserted-by":"crossref","first-page":"e63395","DOI":"10.1371\/journal.pone.0063395","article-title":"High HPV-51 prevalence in invasive cervical cancers: results of a pre-immunization survey in North Sardinia, Italy","volume":"8","author":"Piana","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.amepre.2018.03.015_bib28","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1086\/597309","article-title":"The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16\u201326 years","volume":"199","author":"Wheeler","year":"2009","journal-title":"J Infect Dis"},{"issue":"3","key":"10.1016\/j.amepre.2018.03.015_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/ijc.22527","article-title":"Human papillomavirus type distribution in invasive cervical cancer and high-grade cervical lesions: a meta-analysis update","volume":"121","author":"Smith","year":"2007","journal-title":"Int J Cancer"},{"issue":"2","key":"10.1016\/j.amepre.2018.03.015_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1158\/1055-9965.EPI-14-0649","article-title":"HPV type attribution in high-grade cervical lesions: assessing the potential benefits of vaccines in a population-based evaluation in the United States","volume":"24","author":"Hariri","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"}],"container-title":["American Journal of Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379718316726?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0749379718316726?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,28]],"date-time":"2018-06-28T20:24:08Z","timestamp":1530217448000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0749379718316726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0749379718316726"],"URL":"https:\/\/doi.org\/10.1016\/j.amepre.2018.03.015","relation":{},"ISSN":["0749-3797"],"issn-type":[{"value":"0749-3797","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in High-Grade Cervical Cancer Precursors in the Human Papillomavirus Vaccine Era","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amepre.2018.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}